BEL reported earnings which were strong at 3.97 bn, against a sequential profit of 541 mn. Revenues grew by 16.3%/90.9% yoy/qoq to 31.9 bn, which were robust as the company well executed projects in this quarter despite several challenges. The company was active in supplying ventilators in the quarter which was one of their main projects. On the profitability front, EBITDA margins came in at 19.6% which were down by just 30 bps yoy, but were still in line with our expectations on prompt execution. Sequentially the margins excelled from 8.8% as the base quarter had an impact of pandemic. The PAT as a result of this came in at 3.97 bn, a growth of 17% yoy, which was slightly better than our estimates on higher other income. In Q2, the company...